TheStreet

Log In

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?Don't have an account? Sign Up Here

Join Us

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Already have an account? Login here
TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTTECHNOLOGYMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTER
Search

Trade with Jim Cramer 14 Days Free

Join the Action Alerts PLUS Community today!

SUBSCRIBE NOW

LATEST NEWS

Inovio Lead
Play
INVESTING

5 Stock Gainers for Friday: VBI Vaccines, Moderna, Novavax

  • By Rob Lenihan
  • Jul 17, 2020 4:23 PM EDT
PRESS RELEASES

Dynavax To Present At The H.C. Wainwright Virtual BioConnect 2021 Conference

  • By PR Newswire
  • Jan 6, 2021 4:05 PM EST
PRESS RELEASES

Serum Institute Of India And Dynavax Announce First Participants Dosed In The Phase 1/2 Clinical Trial For A COVID-19 Vaccine

  • By PR Newswire
  • Dec 23, 2020 8:00 AM EST
PRESS RELEASES

European CHMP Adopts Positive Opinion For HEPLISAV-B®, Dynavax's Two Dose Adult Hepatitis B Adjuvanted Vaccine

  • By PR Newswire
  • Dec 10, 2020 4:05 PM EST
PRESS RELEASES

Clover Biopharmaceuticals Announces Positive Phase 1 Data For Its Adjuvanted S-Trimer COVID-19 Vaccine Candidates

  • By Business Wire
  • Dec 4, 2020 3:00 AM EST
PRESS RELEASES

Dynavax To Present At The 3rd Annual Evercore Virtual ISI HealthCONx Conference

  • By PR Newswire
  • Nov 17, 2020 4:05 PM EST
PRESS RELEASES

Dynavax To Present At The Stifel 2020 Virtual Healthcare Conference

  • By PR Newswire
  • Nov 2, 2020 4:05 PM EST
PRESS RELEASES

Medigen's COVID-19 Vaccine Combined With Dynavax's CpG 1018 Adjuvant Receives Taiwan Government Subsidy With First Participant Dosed In Early October

  • By PR Newswire
  • Oct 13, 2020 6:00 AM EDT
PRESS RELEASES

Dynavax Announces Appointment Of New Board Member And Planned Retirement Of Chief Financial Officer

  • By PR Newswire
  • Sep 24, 2020 4:05 PM EDT
PRESS RELEASES

Dynavax To Present At The H.C. Wainwright Virtual 22nd Annual Global Investment Conference

  • By GlobeNewswire
  • Aug 31, 2020 4:10 PM EDT
PRESS RELEASES

Dynavax Announces Grant To Scale Up CpG 1018 Adjuvant Capacity To Support The Global COVID-19 Response

  • By GlobeNewswire
  • Aug 13, 2020 8:00 AM EDT
PRESS RELEASES

TriSalus Life Sciences Acquires Dynavax's SD-101 Oncology Program In Purchase Agreement For Up To $250 Million In Milestone Payments Plus Royalties On Future Net Sales

  • By GlobeNewswire
  • Aug 3, 2020 8:00 AM EDT
PRESS RELEASES

Dynavax To Report Second Quarter 2020 Financial Results And Host Conference Call On August 6, 2020

  • By GlobeNewswire
  • Jul 30, 2020 4:05 PM EDT
PRESS RELEASES

Dynavax And Medigen Announce Collaboration To Develop A Novel Adjuvanted COVID-19 Vaccine Candidate

  • By GlobeNewswire
  • Jul 23, 2020 8:00 AM EDT
PRESS RELEASES

Dynavax Announces The Appointment Of Two New Board Members

  • By GlobeNewswire
  • Jul 21, 2020 4:10 PM EDT
Inovio Lead
INVESTING

5 Stock Gainers for Friday: VBI Vaccines, Moderna, Novavax

  • By Rob Lenihan
  • Jul 17, 2020 4:23 PM EDT
PRESS RELEASES

Dynavax And Mount Sinai Announce Collaboration To Develop A Universal Influenza Vaccine Candidate With CpG 1018 Adjuvant

  • By GlobeNewswire
  • Jul 16, 2020 8:40 AM EDT
PRESS RELEASES

Dynavax Announces First Participants Dosed In Phase 1 Clinical Trial Evaluating Medicago's COVID-19 Vaccine Candidate With Dynavax's CpG 1018 Adjuvant

  • By GlobeNewswire
  • Jul 14, 2020 8:00 AM EDT
PRESS RELEASES

Dynavax And Times Pharmacy Announce Partnership To Offer HEPLISAV-B® Hepatitis B Vaccine To Customers Throughout Oahu, With A Focus On People With Diabetes

  • By GlobeNewswire
  • Jul 10, 2020 4:01 PM EDT
PRESS RELEASES

Dynavax Announces First Participants Dosed In Phase 1 Clinical Trial Evaluating Clover Biopharmaceuticals' COVID-19 S-Trimer Vaccine Candidate With CpG 1018 Adjuvant

  • By GlobeNewswire
  • Jun 19, 2020 6:00 AM EDT
PRESS RELEASES

Dynavax Completes Enrollment Of Clinical Trial Evaluating HEPLISAV-B In Patients Undergoing Hemodialysis

  • By GlobeNewswire
  • Jun 9, 2020 8:00 AM EDT
PRESS RELEASES

Dynavax To Present At The William Blair 40th Annual Growth Stock Conference

  • By GlobeNewswire
  • May 28, 2020 4:05 PM EDT
PRESS RELEASES

Dynavax Technologies Announces Closing Of $80.5 Million Public Offering Of Common Stock And Full Exercise Of Underwriters' Option To Purchase Additional Shares

  • By GlobeNewswire
  • May 27, 2020 4:05 PM EDT
PRESS RELEASES

Dynavax Technologies Announces Pricing Of $70.0 Million Public Offering Of Common Stock

  • By GlobeNewswire
  • May 21, 2020 9:00 PM EDT
PRESS RELEASES

Dynavax Technologies Announces Proposed Public Offering Of Common Stock

  • By GlobeNewswire
  • May 21, 2020 4:01 PM EDT
TheStreet
  • Terms Of Use
  • Privacy Policy
  • Advertise
  • Reprints
  • Customer Service
  • Data
  • Topic Archive
  • Subscriptions
© 2021 TheStreet, Inc. All rights reserved. Action Alerts PLUS is a registered trademark of TheStreet, Inc.